Shubhi Saxena | Pharmaceutical Sciences | Young Researcher Award

Young Researcher Award

Shubhi Saxena
Researcher Shubhi Saxena
Affiliation Chitkara University, Punjab
Country India
Scopus ID 59249007100
Documents 11
Citations 29
h-index 3
Subject Area Pharmaceutical Sciences
Event International Young Scientists Award

Shubhi Saxena

Chitkara University, Punjab, India

Shubhi Saxena, affiliated with Chitkara University, Punjab, has established an emerging research profile within the field of Pharmaceutical Sciences through peer-reviewed publications and scholarly activities. The available bibliometric indicators, including research publications, citations, and h-index, reflect growing academic visibility and an active commitment to advancing pharmaceutical research. Such achievements represent important indicators of research productivity and scholarly influence while supporting continued development in scientific investigation and interdisciplinary collaboration.[1]

Abstract

Shubhi Saxena has contributed to Pharmaceutical Sciences through research publications addressing contemporary scientific and healthcare challenges. Her scholarly record demonstrates consistent participation in research activities, publication in indexed journals, and collaboration within the academic community. Bibliometric indicators available through Scopus show an emerging citation profile that reflects the visibility of her published work. These achievements indicate a commitment to evidence-based research, scientific communication, and continuous professional development, making her research profile suitable for recognition within programs supporting early-career scientific excellence.[1]

Keywords

  • Young Researcher Award
  • Pharmaceutical Sciences
  • Scientific Research
  • Research Publications
  • Academic Excellence
  • Scopus Author

Introduction

Recognition programs for early-career researchers encourage scientific excellence by acknowledging individuals who contribute to research, innovation, and knowledge dissemination. Within Pharmaceutical Sciences, sustained research efforts are essential for improving healthcare outcomes, developing therapeutic strategies, and expanding scientific understanding. Researchers demonstrating consistent publication activity, measurable research impact, and active academic engagement represent valuable contributors to the advancement of science. Academic awards provide encouragement for continued excellence while highlighting contributions that support future scientific progress.[2]

Research Profile

Shubhi Saxena is affiliated with Chitkara University, Punjab, India. According to the available Scopus author profile, her scholarly record includes 11 indexed publications, 29 citations, and an h-index of 3. These indicators demonstrate developing academic visibility and participation in peer-reviewed scientific communication. Her research activities contribute to Pharmaceutical Sciences through investigations that support evidence-based practice and knowledge generation. Continued publication and collaboration are expected to strengthen her academic profile over time.[1]

Research Contributions

The research contributions associated with Shubhi Saxena reflect active participation in pharmaceutical investigations and scientific publication. Through peer-reviewed articles, she has supported the dissemination of research findings relevant to pharmaceutical science and related interdisciplinary fields. Such contributions enhance scientific discussion, encourage collaborative research, and provide valuable references for future investigations. The growing citation record indicates that published studies are being consulted by the wider research community.[3]

Publications

The available Scopus profile records 11 indexed publications covering Pharmaceutical Sciences and related research topics. Publication within recognized scientific journals demonstrates adherence to peer-review standards and contributes to the dissemination of validated scientific knowledge. Indexed publications also improve research accessibility and encourage future scholarly collaboration through citation and academic engagement.[1]

Research Impact

Bibliometric indicators represent one measure of research influence within the scientific community. The current citation count of 29 and an h-index of 3 indicate that the published work has received scholarly attention while demonstrating continuing research visibility. Although quantitative metrics do not fully capture scientific quality, they provide objective evidence of publication usage, citation activity, and academic engagement within Pharmaceutical Sciences.[1]

Award Suitability

Based on the available academic information, Shubhi Saxena demonstrates characteristics commonly associated with emerging research excellence. Her publication record, citation performance, institutional affiliation, and continued participation in scientific research align with the objectives of the International Young Scientists Award. Recognition through the Young Researcher Award would acknowledge demonstrated scholarly productivity while encouraging future contributions to Pharmaceutical Sciences and interdisciplinary scientific research.[2]

Conclusion

Shubhi Saxena has developed a growing academic profile through research publications, measurable citation impact, and active engagement in Pharmaceutical Sciences. Her scholarly achievements demonstrate commitment to scientific investigation, publication, and knowledge dissemination. The available bibliometric evidence supports recognition as an emerging researcher while encouraging continued contributions to academic research, innovation, and professional development within the global scientific community.[1]

External Link

References

  1. Elsevier. (n.d.). Scopus Author Details: Shubhi Saxena, Author ID 59249007100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59249007100
  2. Young Scientist Awards. (n.d.). International Young Scientists Award – Award Information.
    https://youngscientistawards.com/
  3. Beyond the brain barrier: Hybrid nanoparticles orchestrating intelligent neuro-theranostics.
    https://www.sciencedirect.com/science/article/pii/S000186862600179X

Syed Luqman Ali | Drug Design | Best Researcher Award

Mr. Syed Luqman Ali | Drug Design | Best Researcher Award

Researcher, Abdul Wali Khan University Mardan KPK Pakistan, Pakistan

Mr. Syed Luqman Ali is an enthusiastic researcher specializing in bioinformatics, computational biology, vaccine design, cancer, and drug development. Currently pursuing an MPhil in Biochemistry at Abdul Wali Khan University Mardan (2025), he has published extensively on vaccine and drug design using advanced computational techniques like RNA-seq, molecular docking, and simulation. Mr. Ali is a skilled reviewer for several high-impact journals and a lecturer at Metanoia College of Nursing. With expertise in bioinformatics tools and programming languages, he is committed to advancing scientific knowledge in vaccine and drug research.

Publication Profile

Google scholar

Education

Mr. Syed Luqman Ali is currently pursuing his MPhil in Biochemistry at Abdul Wali Khan University Mardan, Pakistan, with an expected graduation in 2025. He completed his Bachelor’s degree in Biochemistry from the same institution in 2022, laying the foundation for his research career. Additionally, he holds a Diploma in Digital Information Technology from the Board of Technical Education Peshawar, Pakistan, earned in 2021. This diverse educational background has equipped him with a strong interdisciplinary skill set, combining biochemistry, digital technology, and computational biology for cutting-edge research.

Research Experience

Mr. Syed Luqman Ali has been an Experimental and Computational Researcher at Abdul Wali Khan University Mardan since 2019. His research focuses on vaccine and drug design, utilizing advanced computational techniques like RNA-seq analysis, molecular docking, and simulation. With extensive experience in leading bioinformatics databases such as KEGG, MetaCyc, and HADDOCK, Mr. Ali is proficient in tools like SnapGene, Cytoscape, and DAVID. His work contributes to the development of innovative vaccines and drug therapies, advancing scientific knowledge in bioinformatics and computational biology.

Technical Certifications

Mr. Syed Luqman Ali has acquired several technical certifications that complement his research expertise. He completed a Data Analysis with R program through Mindluster, enhancing his data analysis skills. Additionally, he has obtained certifications in Data Analysis with Python and Linux from Udemy, further strengthening his computational abilities. Mr. Ali also completed a Content Writing course through the DigiSkills Training Program from Virtual University, Lahore, improving his communication and writing skills for scientific documentation. These certifications underscore his commitment to continuous learning and professional development in bioinformatics and computational biology.

Awards and Achievements

Mr. Syed Luqman Ali has made significant contributions to the scientific community, with multiple publications in high-impact journals, showcasing his research prowess in bioinformatics and computational biology. His work has been recognized by peers and researchers worldwide. Additionally, Mr. Ali serves as a reviewer for several reputed scientific journals, contributing his expertise to the advancement of research. These achievements reflect his dedication to scientific excellence and his active role in shaping future advancements in his field. 📚🖋️🔬

Research Focus

Mr. Syed Luqman Ali’s research spans multiple bioinformatics and computational biology domains, particularly in vaccine and drug design, cancer immunology, and genomics. His work includes multi-epitope vaccine development using immunoinformatics and reverse vaccinology approaches, along with genomic annotation for vaccine target identification. He has contributed significantly to disease diagnostics and drug discovery, especially in areas like tuberculosis, SARS-CoV-2, Leishmania, and autoimmune disorders. His expertise also extends to advanced data analysis, molecular docking, and RNA-seq analysis, employing tools like KEGG, MetaCyc, and HADDOCK. 🧬💻💉

Publication Top Notes

  • Mutational screening of GDAP1 in dysphonia associated with Charcot-Marie-Tooth disease: clinical insights and phenotypic effects
    Cited by: 20
    Year: 2023
  • Vaccinomics-based next-generation multi-epitope chimeric vaccine models prediction against Leishmania tropica – a hierarchical subtractive proteomics and …
    Cited by: 15
    Year: 2023
  • Genomic annotation for vaccine target identification and immunoinformatics-guided multi-epitope-based vaccine design against Songling virus through screening its whole genome …
    Cited by: 12
    Year: 2023
  • Currently trending and futuristic biological modalities in the management of different types of diabetes: A comprehensive review
    Cited by: 9
    Year: 2023
  • Analysis of the capability of IgG antibodies and receptors with their relationships to food tolerance and autoimmune disorders
    Cited by: 6
    Year: 2023
  • Illuminating the Frontier of Drug Discovery: Unleashing the Power of Bioinformatics for Unprecedented Breakthroughs
    Cited by: 4
    Year: 2023
  • Leveraging computer-aided design and artificial intelligence to develop a next-generation multi-epitope tuberculosis vaccine candidate
    Cited by: 1
    Year: 2024
  • Genetic identification and determination of parasites (Babesia, Leptospira and Toxoplasma Gondi) in wild rats
    Cited by: 1
    Year: 2024
  • Placental histology for targeted risk assessment of recurrent spontaneous preterm birth
    Cited by: 1
    Year: 2024
  • Harnessing bioinformatics for the development of a promising multi-epitope vaccine against tuberculosis: The ZL9810L vaccine
    Cited by: 1
    Year: 2024
  • Promising vaccine models against astrovirus MLB2 using integrated vaccinomics and immunoinformatics approaches
    Cited by: 1
    Year: 2024
  • Multi-epitope-based vaccine models prioritization against Astrovirus MLB1 using immunoinformatics and reverse vaccinology approaches
    Cited by: 1
    Year: 2025
  • Exploring advanced genomic and immunoinformatics techniques for identifying drug and vaccine targets against SARS-CoV-2
    Cited by: 1
    Year: 2024
  • A Comprehensive Methodological Review of Major Developments in Bioinformatics Pipelines for Transcriptomic Data Analysis
    Cited by: –
    Year: 2024
Conclusion

Mr. Ali’s solid academic background, innovative research contributions, advanced technical skills, and role as a mentor, he is undoubtedly a strong candidate for the Research for Best Researcher Award. His work in bioinformatics, drug design, vaccine development, and cancer research showcases his dedication to advancing scientific knowledge and making a global impact.